Cell Therapy for Androgenetic Alopecia: Elixir or Trick?

    June 2023 in “Stem cell reviews and reports
    TLDR Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.
    The document "Cell Therapy for Androgenetic Alopecia: Elixir or Trick?" discusses the potential of stem cell therapies for treating Androgenetic Alopecia (AGA), a common form of hair loss affecting approximately 50% of men and 45% of women by the age of 50. Current treatments, including drugs, hair transplantation, and low laser therapy, have limitations and side effects. Stem cell-based therapies, which reactivate hair follicle stem cells to promote growth and regeneration, are gaining attention. Examples of successful stem cell treatments include adipose-derived stem cell component extract (ADSC-CE) for AGA, and the transplantation of human hair follicle mesenchymal stem cells (hHF-MSCs) into the scalp of 27 patients, resulting in increased hair density. However, these therapies face regulatory and safety challenges, including the risk of tumorigenesis and infection transmission. The document concludes that while stem cell therapies offer a promising alternative treatment for hair loss, further research, including double-blind controlled clinical trials, is needed to fully understand their therapeutic potential and safety.
    View this study on link.springer.com →

    Cited in this study